An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

Innovative Medical

Status and phase: Terminated; Phase 4

Conditions: Skin Aging

Treatments: Drug: LubriDerm; Drug: Kinerase Pro+Therapy Line Ultra rich day repair; Drug: Kinerase Pro+Therapy Line day repair, serum, night repair

Study type: Interventional

Funder types: Industry

Identifiers

NCT00492479

5314

Details and patient eligibility

About

The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.

Sex: Female

Ages: 35 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female patients 35-55 years of age with at least moderate signs of facial aging
• Written informed consent
• Likely to complete all study visits and follow study protocol

Exclusion criteria

• Any dermatological or medical condition which would make patient participation unsafe or interfere with study outcomes or measurements

• Known hypersensitivity to any study product or their components

• Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures)

• Prior use of anti-aging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments)

• Planned facial procedures during the study (microdermabrasion, facials, etc)

  o Botox and fillers cannot be used during the trial or for 3 months prior to study entry

• Recent (within 60 days) or concurrent participation in another clinical trial

• Concomitant topical or systemic therapy that my interfere with study measurements or outcomes

• Use of any other topical photoaging/antiaging therapies during the study, other than the prescribed study regimens

• Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning during the study

• Wearing of cosmetics during study visits